ir.agtc.com
- Applied Genetic Technologies CorporationThe Investor Relations website contains information about Applied Genetic Technologies Corporation business for stockholders, potential investors, and financial analysts.
http://ir.agtc.com/
The Investor Relations website contains information about Applied Genetic Technologies Corporation business for stockholders, potential investors, and financial analysts.
http://ir.agtc.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
1.8 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
18
SITE IP
206.200.251.19
LOAD TIME
1.813 sec
SCORE
6.2
- Applied Genetic Technologies Corporation | ir.agtc.com Reviews
https://ir.agtc.com
The Investor Relations website contains information about Applied Genetic Technologies Corporation business for stockholders, potential investors, and financial analysts.
ir.agtc.com
Corporate Governance - Applied Genetic Technologies Corporation
http://ir.agtc.com/corporate-governance.cfm
Nominating and Governance Committee Charter. Add file to Briefcase. 2015 Annual Meeting Documents.
Investor FAQs - Applied Genetic Technologies Corporation
http://ir.agtc.com/faq.cfm
Show all ». Which exchange do AGTC shares trade on? AGTC shares trade on the NASDAQ Global Market under the symbol AGTC. Where is the company located? AGTC is headquartered in Alachua, FL. Our address is:. 14193 NW 119th Terrace, Suite #10. Alachua, Florida 32615. AGTC also has an office in Cambridge, MA:. One Kendall Square, 1400W, Suite B14305. Cambridge, MA 02139. Does AGTC offer a direct stock purchase program? AGTC does not offer a direct stock purchase program. When is AGTC's fiscal year end?
Events & Presentations - Applied Genetic Technologies Corporation
http://ir.agtc.com/eventdetail.cfm?EventID=162841
Details on this event are not available. 2015 Annual Meeting Documents.
Events & Presentations - Applied Genetic Technologies Corporation
http://ir.agtc.com/events.cfm
Jun 21, 2016. Research Day Presentation June 2016. Nov 8, 2016. First Quarter Financial Results Conference Call and Webcast. First Quarter Financial Results Conference Call and Webcast. Please sign up for email alert notification. Nov 15, 2016. Stifel 2016 Healthcare Conference. Stifel 2016 Healthcare Conference. Please sign up for email alert notification. Oct 11, 2016. Sep 12, 2016. Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast. Aug 16, 2016. Jul 13, 2016. Jun 1, 2016.
Committee Composition - Applied Genetic Technologies Corporation
http://ir.agtc.com/committees.cfm
Show all ». Ed earned his Juris Doctor and Master of Business Administration degrees in 1990 from the University of California, Berkeley’s Boalt School of Law and Haas School of Business, respectively. Ed earned a Bachelor of Arts in Molecular Biology from Cornell University in 1985. Member of the Audit Committee. Chair of the Nominating and Governance Committee. Member of the Compensation Committee. Member of the Audit Committee. Chair of the Compensation Committee. David R. Guyer M.D. Dr Koenig receive...
TOTAL PAGES IN THIS WEBSITE
20
Our Expert Team
http://www.agtc.com/about-us/our-team
Industry experts committed to cures. Jeffrey Chulay, M.D., DTM&H. Vice President and Chief Medical Officer. Stephen W. Potter. Mark S. Shearman, Ph.D. Matthew Feinsod, M.D. Rabia Ozden, M. D. Vice President, Clinical Research and Development. David R. Knop, Ph. D. Executive Director, Process Development. Guo-jie Ye, Ph. D. Senior Director, Research and Pre-Clinical Studies. Tavara K. Andrews, CPA. Controller and Director, Finance. Ophthalmology Scientific Advisory Board. Otology Scientific Advisory Board.
Careers and Internships
http://www.agtc.com/careers
Want to join our team? AGTC is a clinical stage biotechnology company developing novel systems to deliver human therapeutics. Our team exceeds expectations every day, placing a high standard on integrity and open communication in all areas of our business enterprise. Open positions are listed via the links below:. Director - Gene Therapy Research. Scientist – Gene Therapy Research. Research Associate - Basic Research. Research Associate - Cloning and Production. Research Associate II - Target Analysis.
David R. Knop, Ph. D.
http://www.agtc.com/bios/detail/david-r.-knop-ph.-d
Industry experts committed to cures. David R. Knop, Ph. D. Executive Director, Process Development. Since AGTC’s inception, Dr. Knop has been responsible for the development of all upstream and downstream unit operations comprising the company’s proprietary rHSV co-infection method for rAAV manufacture. Ophthalmology Scientific Advisory Board. Otology Scientific Advisory Board. Jeffrey Chulay, M.D., DTM&H. Stephen W. Potter. Mark S. Shearman, Ph.D. Matthew Feinsod, M.D. Rabia Ozden, M. D.
Partnerships l Innovative Treatments
http://www.agtc.com/partnership
Working together to develop innovative treatments. Partnerships are a critical part of the AGTC’s growth strategy. The company is actively exploring alliances that complement our expertise in AAV gene therapy product development with important scientific, clinical and business capabilities. These alliances may incorporate our AAV technology platform, product candidates and/or gene therapy product development capabilities. To inquire regarding partnership opportunities with AGTC, please contact:. For Inhe...
Finding Cures for Visual Disorders l Products
http://www.agtc.com/products
We specialize in what's possible. AGTC has several ongoing ophthalmology development programs and proof-of-concept data in multiple indications. AGTC has the option to Co-promote 2nd approved product and the right on both programs to opt into a 50/50 cost sharing and profit sharing relationship. Achromatopsia CNGB3 and CNGA3 (ACHM): an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total loss of color discrimination.
X-Linked Retinitis Pigmentosa
http://www.agtc.com/products/x-linked-retinitis-pigmentosa
XLRP) is inherited condition that causes progressive vision loss in boys and young men. The condition begins with night blindness in young boys followed by progressive constriction of the field of vision. Affected men become legally blind at an average of about 45 years of age. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. RPGR-associated retinal degeneration in human X-linked RP and a murine model. Alachua, Florida 32615.
Stephen W. Potter-OLD LINK
http://www.agtc.com/bios/detail/daniel-l.-menichella
Industry experts committed to cures. Ophthalmology Scientific Advisory Board. Otology Scientific Advisory Board. Jeffrey Chulay, M.D., DTM&H. Stephen W. Potter. Mark S. Shearman, Ph.D. Matthew Feinsod, M.D. Rabia Ozden, M. D. David R. Knop, Ph. D. Guo-jie Ye, Ph. D. Tavara K. Andrews, CPA. 14193 NW 119th Terrace, Suite #10. Alachua, Florida 32615. One Kendall Square, 1400W, Suite B14305. Cambridge, MA 02139. Please enter the letters from the image below in order to prevent spam.
Social Media Disclaimer
http://www.agtc.com/disclaimer
AGTC is dedicated to utilizing cutting-edge techniques to develop treatments for patients around the world with rare eye and lung diseases. As part of that commitment, we seek to provide information about our company, research endeavors, and patient initiatives through social media channels. We appreciate the interest patients, healthcare professionals and other social media users have in learning more about AGTC. We hope the dialogue that takes place within our social media platforms will be valuable.
Frank Sprecher
http://www.agtc.com/bios/detail/frank-sprecher
Industry experts committed to cures. Ophthalmology Scientific Advisory Board. Otology Scientific Advisory Board. Jeffrey Chulay, M.D., DTM&H. Stephen W. Potter. Mark S. Shearman, Ph.D. Matthew Feinsod, M.D. Rabia Ozden, M. D. David R. Knop, Ph. D. Guo-jie Ye, Ph. D. Tavara K. Andrews, CPA. 14193 NW 119th Terrace, Suite #10. Alachua, Florida 32615. One Kendall Square, 1400W, Suite B14305. Cambridge, MA 02139. Please enter the letters from the image below in order to prevent spam.
TOTAL LINKS TO THIS WEBSITE
18
Apollo Global Management LLC. - Investor Relations - Investor Relations
Past Events and Presentations. Since its founding in 1990, Apollo has grown to become one of the world's largest alternative asset managers. 160; 1.04. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Apollo Global Management Announces Strategic Transactions. Apollo Global Management, LLC Reports Second Quarter 2015 Results. Apollo Global Management to Announce Second Quarter 2015 Financial Results and Host Conference Call on July 29, 2015. There are currently no events scheduled. For inquiries b...
Investor Relations Home - Investor Relations - American Capital Agency Corp
Skip to main content. 10-Q Q2 2015 (quarter ending June 30, 2015). American Capital Agency Corp. Reports $(0.97) Comprehensive Loss Per Common Share And $24.00 Net Book Value Per Common Share. American Capital Agency Corp. Declares Monthly Common Stock Dividend of $0.20 per Common Share for July 2015. American Capital Agency Corp. Will Report Second Quarter 2015 Results on July 27; Shareholder Call Scheduled for July 28. Q2 2015 Shareholder Presentation. Q1 2015 Shareholder Presentation. Bank of America ...
Agnico Eagle - Investor Relations
Production Summary and Forecast. Agnico Eagle Acquires Cayden Resources. Materiality and Stakeholder Engagement. Why A Career With Us? Build a high-quality, manageable business that generates superior long-term returns per share by: Increasing gold production in lower risk jurisdictions. Growing operating and free cash flows. Providing meaningful dividends. Minimizing share dilution. Operating in a socially responsible manner. July 29, 2015. June 22, 2015. TSX: AEM (CANADIAN DOLLAR). Aug 14, 2015 03:59 PM.
Agria Corporation | Investor Relations Home
China Seeds R&D Experts. Agria Subsidiary PGG Wrightson Announces Commerce Commission Investigation Update. Agria Subsidiary PGG Wrightson Purchases Australian Arable Seed Business. Agria Subsidiary PGG Wrightson Acquires Strategic Interest in Uruguay. Agria Subsidiary PGG Wrightson Announces Commerce Commission Investigation. There are currently no events scheduled. Agria Reports 1H FY15 Financial Results. First Half FY 2015 Financial Results Conference Call Presentation. Sign up to receive e-mail alert...
Agritek Holdings, Inc. (AGTK)
Building Canna-business From the Ground Up to the Cloud. Agritek Holdings, Inc., the first fully reporting Company and pioneer within the medicinal marijuana sector, provides innovative patient and agricultural solutions and seeks to be the leader in Compassionate Care Technology and indoor/outdoor agricultural solutions for the recreational cannabis industry. Agritek Holdings through its’ wholly owned subsidiary “Agritek Venture Holdings Inc.” provides real estate services includin...The US. cannabi...
- Applied Genetic Technologies Corporation
4:00 PM ET on Aug 14, 2015. Delayed at least 20 minutes. Aug 3, 2015. AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 12, 2015. Jul 6, 2015. AGTC President and CEO to Present at Cantor Healthcare Conference on July 8, 2015. View all news ». Aug 12, 2015 at 9:45 AM ET. Wedbush PacGrow Healthcare Conference. Jul 28, 2015. BMO Capital Markets Biotech Corporate Access Day. View all events and presentations ».
安徽网络电台
AIG - Investor Information
070109 AIG COMPLETES SALE OF 21ST CENTURY INSURANCE TO ZURICH FINANCIAL SERVICES GROUP UNIT. 070109 AIG IN AGREEMENT TO SELL ITS CONSUMER FINANCE OPERATIONS IN COLOMBIA. 062909 AIG TO SELL ITS RUSSIAN BANK SUBSIDIARY TO BANQUE PSA FINANCE.
Investor Overview - Investor Relations - Aimmune
CODIT and Oral Immunotherapy. AR101 for Peanut Allergy. Stock Quote and Chart. Aimmune Therapeutics a 35th Annual J.P. Morgan Healthcare Conference. 160;at 5:00 pm PT. Aimmune Therapeutics a 35th Annual J.P. Morgan Healthcare Conference. Wednesday, January 11, 2017 . 5:00 pm PT . Click here for webcast. Click here to add this event to your calendar. January 4, 2017. Aimmune Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference. December 1, 2016. Aimmune Therapeutics Appoints Scien...
airberlin IR – Investor Relations
Creditor Relations - Anleihen. Raquo; Investor Relations. Airberlin-Aktie, XETRA: 0,04 EUR, 29.03.2018, 17:35. Creditor Relations - Anleihen. Geplanter Erwerb der NIKI Luftfahrt GmbH durch die Deutsche. NIKI Luftfahrt GmbH hat Antrag auf Eröffnung eines. Geplanter Erwerb der NIKI Luftfahrt GmbH durch die Deutsche.
SOCIAL ENGAGEMENT